CASTRATION-RESISTANT PROSTATE CANCER (CRPC): A UK EPIDEMIOLOGY STUDY

被引：5
|
作者：
Morgan, C. [1 ]
McEwan, P. [1 ]
Chamberlain, G. [1 ]
Cabrera, C. [2 ]
Parry, D. [3 ]
机构：
[1] Cardiff Res Consortium, Cardiff, Wales
[2] AstraZeneca, Molndal, Sweden
[3] AstraZeneca, Macclesfield, Cheshire, England
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)72108-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A26 / A26
页数：1
相关论文
共 50 条
  • [1] Castration-resistant prostate cancer (CRPC)
    Loidl, W.
    Luger, F.
    Roosen, A.
    [J]. UROLOGE, 2014, 53 (03): : 391 - 399
  • [2] Castration-resistant prostate cancer (CRPC) [Kastrationsrefraktäres prostatakarzinom (CRPC)]
    Loidl W.
    Luger F.
    Roosen A.
    [J]. Der Urologe, 2014, 53 (3): : 391 - 401
  • [3] Mechanisms of resistance in castration-resistant prostate cancer (CRPC)
    Chandrasekar, Thenappan
    Yang, Joy C.
    Gao, Allen C.
    Evans, Christopher P.
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2015, 4 (03) : 365 - 380
  • [4] Role of Immunotherapy in Castration-Resistant Prostate Cancer (CRPC)
    Suarez, Cristina
    Morales-Barrera, Rafael
    Ramos, Victor
    Nunez, Isaac
    Valverde, Claudia
    Planas, Jacques
    Morote, Juan
    Maldonado, Xavier
    Carles, Joan
    [J]. BJU INTERNATIONAL, 2014, 113 (03) : 367 - 375
  • [5] Novel therapeutics for the management of castration-resistant prostate cancer (CRPC)
    Lee, Daniel J.
    Cha, Eugene K.
    Dubin, Justin M.
    Beltran, Himisha
    Chromecki, Thomas F.
    Fajkovic, Harun
    Scherr, Douglas S.
    Tagawa, Scott T.
    Shariat, Shahrokh F.
    [J]. BJU INTERNATIONAL, 2012, 109 (07) : 968 - +
  • [6] Retreatment with docetaxel in metastatic castration-resistant prostate cancer (CRPC).
    Gernone, A.
    Pagliarulo, A.
    Pagliarulo, V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] DISEASE BURDEN OF CASTRATION-RESISTANT PROSTATE CANCER (CRPC) IN CHINA
    Ma, F. F.
    Liu, Q.
    Wang, J.
    Zhang, X. J.
    Yu, F.
    [J]. VALUE IN HEALTH, 2020, 23 : S451 - S452
  • [8] Second line therapy for castration-resistant prostate cancer (CRPC)
    Molitor, B.
    Boergermann, C.
    [J]. UROLOGE, 2012, 51 (03): : 357 - 362
  • [9] Castration-Resistant Prostate Cancer (CRPC): understanding the mechanisms and implications for management
    Bessede, T.
    Malavaud, B.
    Staerman, F.
    Culine, S.
    [J]. PROGRES EN UROLOGIE, 2013, 23 : 6 - 11
  • [10] CLINICAL STUDY OF MDV3100 IN PROGRESSIVE CASTRATION-RESISTANT PROSTATE CANCER (CRPC)
    Scher, Howard I.
    Beer, Tomasz
    Higano, Celestia
    Efstathiou, Eleni
    Anand, Aseem
    Hirmand, Mohammad
    Hung, David
    Steve, Larson
    Fleisher, Martin
    Sawyers, Charles
    [J]. JOURNAL OF UROLOGY, 2009, 181 (04): : 230 - 230
12345